Technical Analysis for OLK - Olink Holding AB
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | -4.95% | |
Narrow Range Bar | Range Contraction | -4.95% | |
Calm After Storm | Range Contraction | -5.49% | |
Narrow Range Bar | Range Contraction | -5.49% | |
Wide Bands | Range Expansion | -5.49% | |
Overbought Stochastic | Strength | -5.49% | |
Up 3 Days in a Row | Strength | -5.49% | |
Calm After Storm | Range Contraction | -4.92% | |
Narrow Range Bar | Range Contraction | -4.92% | |
Wide Bands | Range Expansion | -4.92% |
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get this analysis on your stocks daily!
- Earnings date: 05/09/2024
Olink Holding AB Description
Olink Holding AB (publ) provides products and services for human protein biomarker discovery worldwide. Its Olink Explore product line include protein biomarker assays primarily for cardiovascular and metabolic diseases, oncology, neurology, and inflammation; Olink Target product line comprise human protein biomarkers for monitoring immune system and downstream applications in clinical trials; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest, or a protein signature. The company also offers Olink Signature Q100, a qPCR readout platform for proximity extension assay; Olink NPX Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of normalized protein expression (NPX) data. In addition, it provides Olink Analysis service comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. The company was founded in 2016 and is headquartered in Uppsala, Sweden.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Natural Sciences Inflammation Molecular Biology Biomarkers Data Processing Gene Expression Bioinformatics Laboratory Techniques Polymerase Chain Reaction Assay Cardiovascular And Metabolic Diseases Real Time Polymerase Chain Reaction
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 26.01 |
52 Week Low | 14.1 |
Average Volume | 706,676 |
200-Day Moving Average | 21.21 |
50-Day Moving Average | 23.97 |
20-Day Moving Average | 23.70 |
10-Day Moving Average | 24.08 |
Average True Range | 0.41 |
RSI (14) | 45.36 |
ADX | 22.71 |
+DI | 20.31 |
-DI | 22.82 |
Chandelier Exit (Long, 3 ATRs) | 23.57 |
Chandelier Exit (Short, 3 ATRs) | 23.11 |
Upper Bollinger Bands | 24.75 |
Lower Bollinger Band | 22.66 |
Percent B (%b) | 0.45 |
BandWidth | 8.81 |
MACD Line | 0.11 |
MACD Signal Line | 0.06 |
MACD Histogram | 0.0522 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 24.54 | ||||
Resistance 3 (R3) | 24.63 | 24.41 | 24.38 | ||
Resistance 2 (R2) | 24.41 | 24.17 | 24.36 | 24.33 | |
Resistance 1 (R1) | 24.00 | 24.02 | 23.89 | 23.91 | 24.28 |
Pivot Point | 23.78 | 23.78 | 23.73 | 23.74 | 23.78 |
Support 1 (S1) | 23.38 | 23.54 | 23.27 | 23.29 | 22.92 |
Support 2 (S2) | 23.16 | 23.40 | 23.11 | 22.87 | |
Support 3 (S3) | 22.75 | 23.16 | 22.82 | ||
Support 4 (S4) | 22.66 |